Parkinson's disease study identifies possible new treatment target

Parkinson’s disease study identifies possible new treatment target

Treatments for Parkinson's disease have most recently focused on increasing dopamine, a chemical messenger in the brain that affects reward-based behaviors and motivation, as well as movement. A new study by Yale researchers challenges long-held assumptions about dopamine's sole role in this disorder.

In people with Parkinson's disease, that produce slowly die. The loss of dopamine leads to slower movements, resting tremors, and other symptoms that worsen over time. To reverse parkinsonism—the collection of symptoms seen in Parkinson's disease—doctors provide a treatment that increases dopamine levels in the striatum, a portion of the brain that is responsible for motor learning. However, do not consider the effects of parkinsonism on another neurotransmitter, acetylcholine.

Scientists had previously believed that when dopamine levels dropped, acetylcholine levels increased. However, this had never been thoroughly investigated, despite acetylcholine's likely role in creating a movement disorder called dyskinesia, which develops in most patients after several years of dopamine treatment for parkinsonism.

To investigate, senior author Nigel S. Bamford and the research team studied healthy mice and mice genetically modified to exhibit parkinsonism with progressively decreasing dopamine levels. In healthy mice, the researchers observed, the ratio of dopamine and acetylcholine remains in equilibrium, and in these chemicals do not significantly impact motor function. In mice with parkinsonism, the reduction in dopamine decreases the activity of a small population of cells within the striatum that are responsible for making acetylcholine. While the concentrations of both dopamine and acetylcholine decline, the balance between these two neurotransmitters shifts to favor acetylcholine. Under these conditions, Bamford and his co-authors learned, motor function in parkinsonism becomes dependent on both dopamine and acetylcholine.

These findings suggest that treating parkinsonism may require targeted therapies that restore the balance between these two chemicals, instead of focusing solely on dopamine, said the researchers. The study is published in the journal Neuron.

Explore further

New method maps the dopamine system in Parkinson's patients

More information: Jonathan W. McKinley et al. Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson's Disease, Neuron (2019). DOI: 10.1016/j.neuron.2019.06.013
Journal information: Neuron

Provided by Yale University
Citation: Parkinson's disease study identifies possible new treatment target (2019, July 17) retrieved 25 August 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Jul 17, 2019

My name is LUCY SETHI from USA .I am here to
give testimony on how I got my husband back.
My husband left me for no reason 3 years ago.
He moved in with another woman, I felt like
killing myself, my life became very bitter and
sorrowful. Then 1 day, a friend of mine told me
about a great spell caster that is very good and,
he said he gave him some lucky numbers that he
played in a lottery and he won. I didn't believe it
because I've worked with so many of them and it
didn't work. He begged me further so I decided
to try this great spell caster called DR TAKUTA. I
still didn't believe. I used the spell he gave me
and the next day I received a call from my
darling husband Thomas last month. He
apologized and came back to me. He even gave
me 10,000USD as a means of compensating me.
I'm very happy now. please i will advise you to contact him
now and see for your self his Email is via____

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more